MIT-owned lab buildings change hands for reported $1.1 billion


A trio of Kendall Square buildings that are home to big-name drug companies traded hands for one of the steepest prices ever seen in Boston’s office market.


Harrison Street Real Estate and Bulfinch Cos. agreed to pay the investment arm of Massachusetts Institute of Technology $1.1B for a long-term lease on the three buildings — 610 Main Street, 700 Main, and One Portland Street in Cambridge.

The cluster of buildings, called the Osborn Triangle, is occupied by Pfizer, Novartis, and startup hub Lab Central, as well as a few smaller tenants.


Read the full article at…


Leave a Reply

Your email address will not be published. Required fields are marked *

More in Ashton Tweed Connection
The top 10 pharma R&D budgets in 2018

Big Pharmas are still the biggest spenders in drug R&D, and the numbers are impressive: Last year, and for the...